Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates

Corcept Therapeutics (CORT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this drug developer would post earnings of $0.37 per share when it actually produced earnings of $0.26, delivering a surprise of -29.73%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Corcept, which bel ...